Objectives This study noninvasively examined the electrical conductivity (σ) characteristics of diffuse gliomas using MRI and tested its validity. Methods MRI including a 3D steady-state free precession (3D SSFP) sequence was performed on 30 glioma patients. The σ maps were reconstructed from the phase images of the 3D SSFP sequence. The σ histogram metrics were extracted and compared among the contrast-enhanced (CET) and noncontrast-enhanced tumour components (NCET) and normal brain parenchyma (NP). Difference in tumour σ histogram metrics among tumour grades and correlation of σ metrics with tumour grades were tested. Validity of σ measurement using this technique was tested by correlating the mean tumour σ values measured using MRI with those measured ex vivo using a dielectric probe. Results Several σ histogram metrics of CET and NCET of diffuse gliomas were significantly higher than NP (Bonferroni-corrected p ≤ .045). The maximum σ of NCET showed a moderate positive correlation with tumour grade (r = .571, Bonferroni-corrected p = .018). The mean tumour σ measured using MRI showed a moderate positive correlation with the σ measured ex vivo (r = .518, p = .040). Conclusions Tissue σ can be evaluated using MRI, incorporation of which may better characterise diffuse gliomas.
Introduction
Electrical conductivity (σ) represents the ability of a material to conduct electric current and is determined mainly by the concentration and/or mobility of sodium ions in the material [1, 2] . Different materials are known to have different σ values, ranging from almost zero (insulators) to several million siemens per meter (S/m) (conductors). Living tissues also have variable σ values: fat and bone have lower σ values, whereas the cerebrospinal fluid (CSF) and blood have higher σ values [3] . Tumours, especially malignant ones, are reported to have higher σ values than do normal tissues [4] .
The knowledge of σ differences between tumours and normal tissues has been applied in medicine for several decades [5] . Before the era of CT and MRI, surgeons used σ differences to localize brain tumours. By placing dielectric probes directly on the brain surface during craniotomies, differences in local tissue electrical impedance (i.e., the inverse of σ) could be identified between brain tumours and normal brain tissue [5] . The surgeons also came to notice the differences in electrical impedance among different types of brain tumours through these procedures, which suggests the possible usefulness of the information about electrical properties in distinguishing brain tumours.
Information about electric properties can also be obtained from MRI, due to the relationship between electricity and magnetism [6] . Haacke et al. were the first to attempt the derivation of electric properties from the measurable magnetic field, using the Helmholtz equation [7] . This effort was followed by further investigations and improvements by other researchers [8, 9] , which led to the estimation of tissue σ values noninvasively and in vivo from the phase maps of MRI scans, a technique termed electric properties tomography (EPT) [6] . Although any other phase maps can be used to calculate σ, EPT typically uses the phase images of a 3D steady-state free precession (3D SSFP) sequence to minimize the effect of B 1 magnetic field inhomogeneities and unwanted phase contributions from flow, motion, and eddy currents in the tissues [6] . EPT represents an improvement over previous techniques because it is completely noninvasive [8, 9] .
The validity of EPT for σ measurement has been tested by comparing the σ values measured by EPT and dielectric probes for saline phantoms containing different saline concentrations [10] . Very high correlation is observed between the two, indicating the validity of EPT for noninvasive σ estimation. However, to our knowledge, no comparison between EPT and dielectric probe of σ in living tissues has been reported. This comparison is important because results from saline phantom measurements cannot be directly applied to living tissues. Regarding the estimation of σ in living tissues by EPT, previous studies have reported on the σ EPT characteristics of normal brain tissues [11, 12] . In agreement with the literature, these reports observe that the σ of the CSF is higher than that of the normal grey matter, which in turn has a higher σ than that of normal white matter [3] . The clinical applicability of EPT has also been documented in breast and cervical cancers [13, 14] . However, its usefulness in other diseases or body regions has not been well explored.
This study tested the validity of noninvasive σ measurement by EPT by correlating the σ of brain tumours measured in vivo by EPT (σ EPT ) with that measured ex vivo by a dielectric probe (σ PROBE ). The σ characteristics of diffuse gliomas were also examined using EPT to evaluate if noninvasive σ measurements could be useful in grading these tumours.
Materials and methods

Patients
This retrospective study was approved by the local institutional review board. Written informed consent for contrastenhanced MR examination was obtained from all patients. EPT was performed as a part of the routine protocol, and the magnitude images were used to obtain morphological information on brain tumours. The requirement of written informed consent for EPT was waived.
MR images of patients with diffuse gliomas were collected from our hospital database. The recruitment period was 35 months (February 2013 through December 2015), and the inclusion criterion was the diagnosis of diffuse gliomas. Diagnoses were principally made by histological confirmation (i.e., the hospital pathology reports were referred for the final diagnoses). In patients who did not undergo surgery or biopsy, diagnoses were obtained by hospital radiology reports made at or closest to the time of EPT imaging. We included only those patients in whom MRI and PET imaging (one or more of the following:
18 F-fludeoxyglucose-PET, 11 C-methionine-PET, and 18 F-fluoromisonidazole-PET) reports suggested the same tumour grade. For both histological and radiological grading, tumour grades were determined in accordance with the WHO classifications [15] . The exclusion criteria were any prior treatment, equivocal or unconfirmed diagnosis, failure to acquire the 3D SSFP sequence, and visible artefacts on the phase maps of the 3D SSFP sequence.
Of 72 possible patients, 42 were excluded for prior treatments such as tumour debulking surgery, radiation, or chemotherapy (n = 15); equivocal or unconfirmed diagnoses (n = 5); lack of a 3D SSFP sequence (i.e., scans were performed with scanners incapable of 3D SSFP imaging or patients failed to complete the MRI protocol) (n = 21); and visible motioninduced ghosting artefacts on the phase maps of the 3D SSFP sequence (n = 1). Thirty patients (mean age ± standard deviation = 50.73 ± 18.21 years, age range = 12-84 years; 14 men and 16 women; eight grade II, 11 grade III, and 11 grade IV tumours) eligible for this study (Fig. 1) . A summary about patient characteristics is given in Table 1 .
Ex vivo σ measurement
Pieces of the resected tumour tissues of patients who underwent subsequent surgery or biopsy were used for ex vivo σ measurement. From 30 patients, 16 tumour samples (three grade II, four grade III, and nine grade IV tumours) were available. These samples were initially stored in a frozen state (-80°C) at the Department of Neurosurgery of the institution and were thawed to room temperature (the mean water temperature ± standard deviation = 23.21 ± 0.59°C), just before the measurement of σ PROBE values. A dielectric probe (N1500A, Keysight Technologies, USA) and an analyser (N9918A, Keysight Technologies, USA) were used to measure σ PROBE . All measurements were done by a researcher trained for σ PROBE measurement. Five measurements were conducted for each tumour sample, and the mean value was used. To remove observer bias, the σ EPT values and histological information about the samples were blinded to the researcher who performed the measurements.
MRI
EPT was conducted using a 3D SSFP sequence taken with nonselective radiofrequency (RF) pulses and a 3 T-MR imager (Achieva TX, Philips Medical Systems, Best, the Netherlands). A standard 32-channel RF head coil (Philips Medical Systems, Best, the Netherlands) was used for signal reception. The SSFP images were divided by the sensitivity profile of this RF coil, which was measured using a built-in pre-scan, to remove unwanted image contributions. The scan parameters were: repetition time/echo time/flip angle/number of excitation = 3.5 ms/1.7 ms/25°/2, acquisition voxel size = 1.3 × 1.2 × 1 mm , slice orientation = sagittal, acquisition time = 3 min 40 s. The σ EPT maps were calculated essentially as the second spatial derivative from three dimensions of the phase maps, implemented by in-house software written in the C programming language. The details are described in the BElectronic supplementary material^section.
In addition to EPT, axial pre-and postcontrast-enhanced T1-weighted imaging, T2-weighted imaging, and fluidattenuated inversion recovery (FLAIR) imaging were also conducted. All MRI sequences, except postcontrastenhanced T1-weighted imaging, were acquired before contrast administration. Image quality was assured throughout the study by ruling out any variation in magnetic field homogeneity, coil sensitivity profile, and artefacts in daily phantom scans performed by an experienced technologist. Since the phase information of image data is particularly important in this study, we also made sure that there were no issues regarding this by performing susceptibility-weighted imaging, which is highly sensitive to phase. All MRI measurements were performed under the normal operating mode, and the specific absorption rate was kept below 3.2 W/kg/10 min [16] . 
Image processing
Image processing involved segmentation of the contrastenhanced tumour component (CET), noncontrastenhanced tumour component (NCET), and the normal brain parenchyma (NP) of each patient, for measurement of the σ E P T values. This process included image coregistration (SPM12, Wellcome Trust Centre for Neuroimaging, University College of London, Oxford, UK); determination of the signal intensity range for CET, NCET, and NP (MRICron Version 1, www.mricro.com); and erosion (Image J 1.50i, National Institutes of Health, Bethesda, MD, USA). Segmentation of the resected tumour area was also performed in patients for which tumour samples were available to compare the σ EPT and σ PROBE values. These steps are detailed in Fig. 2 and the BElectronic supplementary material^section.
Image evaluation
The validity of noninvasive σ measurements by EPT was tested by correlating the mean σ EPT of the resected tumour area with the ex vivo σ PROBE value. Pearson's productmoment correlation analysis was used for this purpose. To represent better the σ characteristics of each tumour component, histogram analysis was used to evaluate the σ EPT values. For each tumour component and NP, the mean, minimum, maximum, mode, quartiles, skewness, and kurtosis of the σ EPT values were derived (Image J 1.50i). The differences in σ EPT among the CET, NCET, and NP were tested using one of the following testing approaches: repeated-measures analysis of variance (ANOVA) and post hoc Bonferroni tests, Friedman and post hoc Wilcoxon signed-rank tests, or paired t-tests. Different approaches were chosen based on the normality of data distribution and the number of levels formed by the variables. Repeated-measures ANOVA and post hoc Bonferroni tests were used when the data were normally distributed and had three levels (CE, NCE, and NP). Friedman and post hoc Wilcoxon signed-rank tests were used when the data were not normally distributed but had three levels. Paired t-tests were used for normally-distributed data with only two levels (i.e., CE and NP or NCE and NP only). The σ EPT values were also tested for correlation with tumour grade using Pearson's product-moment correlation analysis. The accuracy of EPT in distinguishing glioma grades was then compared with that of radiologists using routine MRI findings (radiological reports) through receiver-operating characteristic (ROC) analyses. For all analyses, a Bonferroni-corrected p < .050 was considered statistically significant. Statistical analyses were performed by using SPSS version 14.0 (IBM, Armonk, NY, USA).
Results
Validity of noninvasive σ measurement by EPT
The mean σ EPT of the resected tumour area showed a moderate positive correlation with the σ PROBE values measured ex vivo (r = .518, p = .040) (Fig. 3) .
Glioma σ EPT values
The representative σ EPT maps of grade II to grade IV gliomas and the corresponding postcontrast-enhanced T1-weighted and FLAIR images are shown in Fig. 4a, b , and c. The mean values of the σ EPT histogram metrics are summarized in Table 2 . For the grade IV tumours, the mean σ EPT values significantly differed among the CET, NCET, and NP. CET showed the highest values, followed in descending order by NCET and NP (Bonferroni-corrected p ≤ .015). The maximum, median, mode, and 25th and 75th percentiles of both CET and NCET were significantly higher than those of NP (Bonferroni-corrected p < .003). For the grade III tumours, the maximum and 75th percentile of both NCET and CET were significantly higher than those of NP (Bonferronicorrected p ≤ .045). The mean, median, and 25th percentile of the σ EPT of NCET were significantly higher than those of NP (Bonferroni-corrected p ≤ .042). The mean and median σ EP T of CET tended to be higher than those of NP (Bonferroni-corrected p ≤ .060). Statistical comparison of the σ EPT of CET with those of NCET and NP was impossible for the grade II tumours due to an insufficient number of tumours with contrast enhancement (n = 1). The mean, median, mode, minimum, maximum, and the 25th and 75th percentiles of NCET were significantly higher than those of NP (Bonferroni-corrected p ≤ .008). Among the tumour grades, the maximum and 75th percentile of NCET in the grade IV tumours were significantly higher than those in the grade II tumours (Bonferroni-corrected p ≤ .036). The maximum, median, and 75th percentile of CET in the grade IV tumours were significantly higher than those in the grade III tumours (Bonferroni-corrected p ≤ .040).
Correlation of σ EPT with tumour grade
The maximum σ EPT of NCET showed significant moderate positive correlation with tumour grade (r = .571, Bonferronicorrected p = .018). The 75th percentile of NCET tended to show a moderate positive correlation with tumour grade (r = .534, Bonferroni-corrected p = .054).
Accuracy of EPT in distinguishing glioma grades
The maximum σ EPT of CET {area under curve (AUC) = .833, p = .027}, as well as the maximum (AUC = .894, p = .009) and the 75th percentile (AUC = .894, p = .009) of NCET, could distinguish the grade IV tumours from the other tumour grades. Each aforementioned metric was more accurate in distinguishing grade IV tumours from lower-grade gliomas (AUC = 1.000, p = .046) than was preoperative MRI grading by radiologists (AUC = .750, p = .317) (n = 15).
Discussion
To our knowledge, this is the first study to examine the validity of noninvasive σ measurements by using MRI and the σ EPT characteristics of diffuse gliomas. We used all of the major histogram metrics, instead of only the mean values, to Fig. 3 Scatterplots showing correlation between the mean electrical conductivity (σ) value of the resected tumour area measured noninvasively by electric properties tomography (EPT) and that by a dielectric probe. The straight and curved lines indicate the mean and 95% confidence interval characterise better the σ EPT values [17] . Our results indicate that EPT can be used to estimate the tissue σ values. This σ EPT information can help better characterise diffuse gliomas and differentiate tumour grades. The mean σ EPT of resected tumour area showed a moderate positive correlation with the σ PROBE values. However, a previous experiment using saline phantoms found an excellent correlation between σ EPT and σ PROBE values [10] . This difference may be attributed to the different natures of the two studies. The former compared σ between the in vivo and ex vivo tissues, whereas the latter was conducted under an experimental setting. The σ values are generally thought to be influenced by tissue sodium ion concentration and mobility [1, 2] . Ion mobility may have been altered in the resected tumour samples, resulting in a change in the σ PROBE values. The difference in the temperatures at which measurements were conducted-body temperature (approximately 37°C) for the in vivo measurements and room temperature (23.21 ± 0.59°C) for the ex vivo measurements-may also be responsible. Generally, σ increases with temperature by approximately 2%/°C [18] . However, this global scale, if taken into account, would not change the observed correlation between the σ EPT and σ PROBE values. Freezing and thawing might also have affected the σ PROBE values because sodium concentration has been reported to differ between the two conditions [19] , although our results from chicken breast phantoms frozen to -80°C then thawed to room temperature did not reveal any significant difference in σ PROBE values between the two temperatures (results not shown). Additionally, the ex vivo measurements were performed only on a piece of resected tumour, whereas the in vivo measurements included the entire resected tumour area, which may explain the disparity of σ values between EPT and dielectric probe measurements. Finally, σ EPT values are often subjected to boundary errors and B 0 magnetic field inhomogeneities [20] , which are more prominent in living subjects.
The σ EPT values of CET and NCET in gliomas were significantly higher than those of NP, suggesting the possible utility of σ EPT for identifying different tumour compartments. A previous study on sodium MR imaging of brain tumours observed increased sodium concentrations in gliomas compared to those in NP [21] . Our observation of increased σ EPT values in diffuse gliomas is also thought to reflect increased sodium ion concentrations within the tumours [2] . As proposed by the previous report [21] , increased tumour sodium content may be due to increases in the intracellular sodium within rapidly proliferating tumour cells and/or the extracellular sodium within the interstitial space that enters tumours through the defective blood-brain barrier. The destruction of myelin, which serves as an insulator of electric current, and neovascularisation may also contribute [11, 22, 23] . The observation of higher mean σ EPT values for CET than for NCET in the grade IV tumours suggests that the CET contains more rapidly proliferating tumour cells than does NCET. The flux of extracellular sodium to the tumour through the defective blood-brain barrier may also be responsible [24] .
Several σ EPT histogram metrics differed significantly among the three tumour grades. The maximum σ EPT of NCET also showed a moderate positive correlation with tumour grade. These findings suggest the potential usefulness of σ EPT in grading diffuse gliomas. Higher σ EPT values in higher-grade gliomas may be due to higher sodium ion concentrations within the tumours. This finding agrees with the observation that tissue sodium content is higher in the rapidly proliferating cells [21] . The role of ion mobility on the σ EPT characteristics is less clear. Although ion mobility may increase in higher-grade gliomas due to necrosis and the disruption of cell membranes, which hinder molecular motion, ion mobility may also be limited by increased tumour cell density [25] . This issue should be clarified in future research.
A few limitations must be addressed. First, to obtain more reliable results, identical pieces of tumour tissue should be used to measure both σ PROBE and σ EPT . While this flaw is an unavoidable limitation of a retrospective study, our results suggest the potential utility of EPT for noninvasive measurement of the σ values of living tissues. Second, the sample size for each grade of glioma is small. This situation prevented the comparison of σ EPT between CET and NCET or NP for grade II gliomas. Further studies with larger sample sizes are warranted to confirm our results.
In conclusion, this preliminary study demonstrated the validity of EPT and its potential usefulness in the evaluation of diffuse gliomas. Possible acquisition of EPT with scanners capable of 3D SSFP sequence without the need for specially designed head coils and provision of a new image contrast based on the σ characteristics may also be the additional values for EPT. The physiological background of tissue σ values requires further investigation. 
